PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29115506-6	2018	The results of the present study ndicated that Ang II upregulated MCP-1 expression in osteoblasts, which was mitigated by agonists of the AT1R, including olmesartan, a ROS scavenger N-acetylcysteine (NAC), ammonium pyrrolidinethiocarbamate (PDTC) and nuclear factor (NF)-kappaB, but not by the Ang II type 2 receptor antagonist, PD123319.	olmesartan	154-164	angiogenin	Homo sapiens	47-50	
19804316-5	2008	Olmesartan has demonstrated its dose-dependent inhibitory effect on Ang I-induced blood pressure responses between 10 and 80 mg in Phase II studies.	olmesartan	0-10	angiogenin	Homo sapiens	68-71	
20104189-6	2010	RESULTS: The blood pressure response to Ang II was blocked by more than 90% with irbesartan alone or in association with HCTZ and with olmesartan/HCTZ and by nearly 60% with valsartan/HCTZ and losartan/HCTZ (P < 0.05).	olmesartan	135-145	angiogenin	Homo sapiens	40-43	
20104189-8	2010	Irbesartan +/- HCTZ and olmesartan/HCTZ blocked the renal hemodynamic response to Ang II nearly completely, whereas valsartan/HCTZ and losartan/HCTZ only blunted this effect by 34 and 45%, respectively.	olmesartan	24-34	angiogenin	Homo sapiens	82-85